HilleVax Is Exploring the Potential for Continued Development of Its Norovirus Vaccine Candidates in Adults as Well as Business Development Related Activities and Other Strategic Alternatives >HLVX
HilleVax Is Exploring the Potential for Continued Development of Its Norovirus Vaccine Candidates in Adults as Well as Business Development Related Activities and Other Strategic Alternatives >HLVX
HilleVax正在探索其諾如病毒成人疫苗候選品繼續發展的潛力，以及與業務發展相關的活動和其他戰略選擇。>HLVX
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間